Hypertension Clinical Trials

Showing 1661-1680 of 1,710 trials

The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive Patients

NCT00728858

Nifedipine and barnidipine act as calcium channel blockers, and are widely prescribed for pressure control of prehypertension and stage 1 hypertension. CYP3A4 is responsible for the metabolism of nifedipine and nifedipine, while the contribution of CYP3A5 remains ambiguous. This study is aimed to analyze the association between antihypertensive effects of nifedipine as well as barnidipine and single nucleotide polymorphisms of CYP3A4, CYP3A5 and calcium channels.

Hypertension

National Taiwan University Hospital43 participantsStarted Apr 2006

COMPLETEDPhase 4

Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension

NCT00061503

The primary objective of this study is to describe the effect of TRAVATAN 0.004% Ophthalmic Solution on aqueous humor dynamics in subjects with a clinical diagnosis of open angle glaucoma (OAG) or ocular hypertension (OHT).

GlaucomaOcular Hypertension

Alcon ResearchStarted Apr 2003

Call For Details, Nebraska, United States

COMPLETEDPhase 3

Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70

NCT00047541

To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.

Open-Angle GlaucomaOcular Hypertension

Alcon ResearchStarted Feb 2001

Fort Worth, Texas, United States

COMPLETEDPhase 4

Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)

NCT00233532

The TRAIL study was conducted to examine the effects of escalating doses of an ACE inhibitor, trandolapril, on lowering blood pressure in Stage 1-2 hypertensive patients.

Hypertension

Abbott2,000 participantsStarted Mar 2004

COMPLETEDPhase 4

Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension

NCT00400777

This study is designed to evaluate the efficacy and safety of the combination valsartan with hydrochlorothiazide and amlodipine in hypertensive patients previously treated with valsartan with hydrochlorothiazide and remaining uncontrolled. A naturalistic approach will be taken comparing two different possible ways to achieve the higher dosage of the triple combination, i.e. 160 mg of valsartan and 25 mg of hydrochlorothiazide with amlodipine 10 mg.

Hypertension

Novartis460 participantsStarted Aug 2006

Rio de Janeiro, Brazil

The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive Patients

Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension

Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70

Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)

Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension

Related Searches

Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months

LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.

Intervention Study to Control High Blood Pressure for Korean American

APROVE : Irbesartan in Hypertension

The Effect of the Patient Activation Measure on Chronic Care

Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans

Potential Risk Factors for Stroke

ICA-CHAMP: Indo-Central Asian Cardiovascular Health Assessment and Management Program

PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension

Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH

Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension

Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%

Cognitive/Cerebrovascular Consequences of HTN Treatment

Remifentanil for General Anesthesia in Preeclamptics

Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension